Abstract
Phospholipase A2 (EC 3.1.1.4) is a family of phosphatide 2-acylhydrolases that play an important role in the metabolism of phospholipids and membrane homeostasis [1–4]. These functions of phospholipase A2 seem relevant to the pathogenesis of various clinical conditions, since the presence of high concentrations of phospholipase A2 activity in plasma and inflammatory exudates of patients suffering from inflammatory arthritis, peritonitis and septic shock has been reported. Administration of exogenous extracellular phospholipase into experimental animals causes inflammatory hyperemia [5], and a correlation of serum levels of phospholipase A2 with the magnitude of hypotension has been shown in endotoxin shock [6,7]. The possible pathogenetic role of soluble phospholipase A2 in endotoxin shock in connection to the cytokine network has been emphasized by several reports showing the secretion of type II phospholipase A2 by rat mesangial cells [8,9], liver cells [1011] and human synovial cells [12,13] in response to tumor necrosis factor and interleukin lß. A recent report from this laboratory has shown the presence of high amounts of PAF associated with the platelets of patients with septicemia [14] and this raises the question as to whether this finding might be related to the secretion of phospholipase A2 activity and an ensuing formation of lipid mediators.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
van den Bosch H. Biochim Biophys Acta 604, 1980: 191–246.
Bereziat G, Etienne J, Kokkinidis M, Olivier JL, Pernas P. J Lipid Mediators 2, 1990: 159–172.
Irvine RF. Biochem J 101, 1982: 53–61.
Snyder F. Med Res Rev 5, 1985: 107–140.
Vadas P, Wasi S, Movat H, Hay JH. Nature 293, 1981: 583–585.
Vadas P. J Lab Clin Med. 104, 1984: 873–881.
Vadas P, Pruzanski W, Stefanski E, Sternby B, Mustard R, Bohnen J, Fraser I, Farewell V, Bombardier C. Crit Care Med 16, 1988: 1–7.
Schalkwijk C, Pfeilschifter J, Marki F, van den Bosch H. Biochem Biophys Res Commun 174, 1991: 268–275.
Pfeilschifter J, Leighton J, Pignat W, Marki F, Vosbeck K. Biochem J 273, 1991: 199–204.
Inada M, Tojo H, Kawata S, Seiichiro T, Okamoto M. Biochem Biophys Res Commun 174, 1991: 1077–1083.
Crowl, R.M., T.J. Stoller, R.R. Conroy, and C.R. Stoner. 1991. J Biol Chem 266, 1991: 2647–2651.
Chang, J, Gilman, SC, Lewis AJ. J. Immunol. 136, 1986: 1283–1287.
Godfrey RW, Johnson WJ, Hoffstein ST. Biochem Biophys Res Commun 142, 1987: 235–241.
Lopez Diez F, Nieto ML, Fernandez-Gallardo S, Gijón MA, Sanchez Crespo M. J Clin Invest 83, 1989: 1733–1740.
Heath MF, Tighe D, Moss R, Bennet D. Crit Care Med 18, 1990: 766–767.
Wright GW, Ooi CE, Weiss J, Eisbach P. J Biol Chem 265, 1990: 6675–6681.
Parthasarathy S, Barnett J. Proc Natl Acad Sci USA 87, 1990: 9741–9745.
Bone RC, Fisher CJ, Clemmer, TP, Slotman GJ, Metz CA, Balk RA. Grit Care Med 17, 1989: 389–393.
Knauss WA, Draper EA, Wagner DP, Zimmerman JE. Crit Care Med. 13, 1985: 818–819.
Bradford M. Anal Biochem 72, 1976: 248–254.
Eisbach P, Weiss J, Franson R, Beckerdite-Quagliata S, Schneider A, Harris L. J Biol Chem 254, 1979: 11000–11009.
Puijk WC, Verheij HM, De Haas GH. Biochim Biophys Acta 492, 1977: 254–259.
Verheij HM, Westerman J, Sternby B, De Haas GH. Biochim Biophys Acta 747, 1983: 93–99.
Kramer RM, Checani GC, Deykin A, Pritzker CR, Deykin D. Biochim Biophys Acta 878, 1986: 394–403.
Kramer RM, Hession C, Johansen B, Hayes G, McGray P, Pingchang Chow E, Tizard R, Blake Pepinsky R. J Biol Chem 264, 1989: 5568–5575.
Lyons-Giordano B, Davis GL, Galbraith W, Pratta MA, Arner EC. Biochem Biophys Res Commun 164, 1989: 488–495.
Lai C-Y, Wada K. Biochem Biophys Res Commun 157, 1988: 488–493.
Kanda A, Ono T, Yoshida N, Tojo H, Okamoto M. Biochem Biophys Res Commun 163, 1989: 42–48.
Seilhamer JJ, Pruzanski W, Vadas P, Plant S, Miller JA, Kloss JY, Johnson LK. J Biol Chem 264, 1989: 5335–5338.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Gijón, M.A., García, C., Pérez, C., López-Díez, F., Sánchez-Crespo, M. (1994). Study of Some Mechanisms that may Contribute to the Presence of High Levels of Phospholipase A2 Activity in Plasma of Patients with Septicemia. In: Mackness, M.I., Clerc, M. (eds) Esterases, Lipases, and Phospholipases. NATO ASI Series, vol 266. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0993-0_28
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0993-0_28
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0995-4
Online ISBN: 978-1-4899-0993-0
eBook Packages: Springer Book Archive